Piroxicam Market

Piroxicam Market Size, Share & Industry Analysis, By Application (Osteoarthritis Relief, Rheumatoid Arthritis, Postoperative Pain), By End-User Industries (Pharmaceuticals, Orthopedic Clinics, Hospitals, Research Institutions), and Forecast, 2025–2035

The global Piroxicam market is projected to grow at a CAGR of 4.4% during the forecast period, driven by its continued use as a nonsteroidal anti-inflammatory drug (NSAID) in managing pain and inflammation associated with osteoarthritis, rheumatoid arthritis, and postoperative conditions. Piroxicam works by inhibiting prostaglandin synthesis, offering long-lasting analgesic and anti-inflammatory effects through once-daily dosing.

Regionally, North America currently leads the market due to high demand for effective arthritis treatments, widespread regulatory approval, and an aging population requiring chronic pain management. The Asia-Pacific region is expected to witness the fastest growth, driven by rising musculoskeletal disorders, expanding access to generic medications, and increased production capacities in India and China. Europe remains a steady contributor to the market, supported by continued usage in orthopedic and hospital-based care.

The Piroxicam market report offers comprehensive insights into manufacturing methods, pricing trends, regulatory landscapes, and therapeutic application shifts. With a stable role in pain management and inflammatory conditions, Piroxicam remains a key pharmaceutical ingredient for drug manufacturers, orthopedic clinics, hospitals, and research institutions focused on chronic inflammation and joint health.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

  1. Introduction
  • Overview of Piroxicam
  • Key End-User & Industry Use Cases
  • Market Scope & Study Objectives
  1. Market Overview
  • Global Market Size & Growth Trends (Historical & Forecast)
  • Demand-Supply Dynamics
  1. Segmental Outlook
  • By Application
    • Osteoarthritis Relief
    • Rheumatoid Arthritis
    • Postoperative Pain
  • Key End-User Industries
  • Pharmaceuticals
  • Orthopedic Clinics
  • Hospitals
  • Research Institutions
  1. Price Analysis
  • Current Price Trends (Per kg & Per Ton)
  • Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
  • Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
  1. Trade Analysis
  • Major Exporting & Importing Countries
  • Trade Volume & Value Statistics
  • Impact of Trade Regulations & Policies
  1. Regional Analysis
  • North America (US and Canada)
  • Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
  • Rest of the World (Latin America, and Middle East, and Africa)
  1. Competitive Landscape
  • Top Global Manufacturers & Production Capacity
  • Company Profiles & Key Developments
    • Sun Pharmaceutical Industries Ltd.
    • Cipla Ltd.
    • Dr. Reddy’s Laboratories Ltd.
    • Aurobindo Pharma Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Intas Pharmaceuticals Ltd.
    • Alkem Laboratories Ltd.
    • Zydus Lifesciences Ltd.
    • Jubilant Ingrevia Ltd.
    • Lupin Ltd.
    • Macleods Pharmaceuticals Ltd.
    • Hetero Drugs Ltd.
    • Apotex Inc.
    • SimSon Pharma Limited
    • Clearsynth Labs Ltd.
    • LGM Pharma
    • Laurus Labs
    • TCI Chemicals Pvt. Ltd.
    • Suven Pharmaceuticals Ltd.
    • Shreeji Pharma International
  • Mergers, Acquisitions & Investments
  1. Regulatory & Compliance Factors
  • FDA, REACH, and Other Regulatory Frameworks
  • Environmental & Safety Considerations
  • Emerging Policies Impacting Market Growth
  1. Conclusion & Strategic Recommendations
  • Key Takeaways for Stakeholders
  • Market Entry Strategies
What is Piroxicam API?
Piroxicam is the active pharmaceutical ingredient used in nonsteroidal anti-inflammatory drugs (NSAIDs) for the treatment of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, and postoperative conditions.
What is the market size for Piroxicam?
The Piroxicam API market is growing at a CAGR of 4.4% during the forecast period from 2025 to 2035, supported by increasing demand for chronic pain relief medications and cost-effective anti-inflammatory therapies.
What are the drivers for the Piroxicam Market?
Key drivers include the rising prevalence of arthritis and musculoskeletal disorders, aging global populations, increased preference for long-acting NSAIDs, and expansion of generic pharmaceutical manufacturing in emerging markets.
Who are the key players operating in the Piroxicam Market?
Major players include Sun Pharma, Cipla, Dr. Reddy’s Laboratories, Teva Pharmaceuticals, Aurobindo Pharma, and Jubilant Ingrevia.
Which region would exhibit the fastest growth in the Piroxicam Market?
The Asia-Pacific region is expected to exhibit the fastest growth due to rising demand for affordable NSAIDs, increasing geriatric population, and rapid expansion of API manufacturing capabilities in India and China.
$1800/- Single User License
$3600/- Multi User License

How can we help you?

Reach out to discuss how our team can help your business achieve real results.